Clinical Trials Browser

Phase 1 × fosaprepitant × Clear all

NCT04636632 2022-11-07

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 1 Completed

Nasopharyngeal Carcinoma

NCT01649258 2017-11-17

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Phase 1 Terminated

Breast Neoplasms, Nausea, Vomiting